Drug Treatment Patterns and Survival Among Patients with Metastatic or Recurrent Soft Tissue Sarcoma (m/rSTS) Refractory to at Least One Prior Therapy

Trial description: Limited clinical data are available about the care of patients with metastatic/recurrent soft tissue sarcoma (m/rSTS) and real-world practice patterns. This study evaluates drug treatment patterns and outcomes in m/rSTS subjects following failure of prior chemotherapy.The primary purpose of this study is to evaluate drug treatment patterns in m/rSTS subjects following failure of prior chemotherapy, based on data from a referral academic cancer center in the United States. Data from medical records consented for research use will be retrospectively reviewed at Dana-Farber Cancer Institute for subjects with m/rSTS who were aged 18 years or older, commenced second-line systemic therapy between 1 January 2000 and 2 April 2011, had confirmed disease progression on or after first-line therapy and had at least 3 months of observation.The study design is a retrospective, observational chart review.